CSIMarket
 


Nuvation Bio Inc   (NUVB)
Other Ticker:  
 

Cumulative Nuvation Bio Inc 's Leverage Ratio for Trailing Twelve Months Period

NUVB's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

NUVB Leverage Ratio for Trailing Twelve Months Period

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity Growth -8.44 % -9.88 % -11.4 % -12.19 % -13.18 %
Y / Y Total Liabilities Growth 3.92 % -37.06 % -43.4 % -43.41 % -34.73 %
Leverage Ratio for Trailing Twelve Months Period 0.03 0.03 0.03 0.03 0.04
Total Ranking # 22 # 20 # 30 # 34 # 56
Seq. Equity Growth -2.09 % -2.56 % -2.14 % -1.93 % -3.63 %
Seq. Total Liabilities Growth 14.92 % 4.95 % -6.32 % -8.03 % -30.4 %


Leverage Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2023
On the trailing twelve months basis Despite net new borrowings of 14.92% Nuvation Bio Inc managed to unchange Leverage Ratio for Trailing Twelve Months Period in III. Quarter to 0.03, a new company low.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Major Pharmaceutical Preparations industry 7 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Nuvation Bio Inc . While total ranking remained unchanged compare to previous quarter at no. .

What is Leverage Ratio?
Who are NUVB's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 8
Sector # 9
S&P 500 # 29


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
0.21 0.06 0.03
(Jun 30 2021)  




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Leverage Ratio for Trailing Twelve Months Period
Sio Gene Therapies Inc   0.07 
Rallybio Corporation  0.07 
Structure Therapeutics Inc   0.07 
Kura Oncology Inc   0.07 
Eledon Pharmaceuticals Inc   0.07 
Cassava Sciences Inc  0.07 
Pardes Biosciences Inc   0.06 
Eqrx Inc   0.06 
Edgewise Therapeutics inc   0.06 
Lipocine Inc   0.06 
Dice Therapeutics Inc   0.06 
Viking Therapeutics Inc   0.06 
Lixte Biotechnology Holdings Inc   0.06 
Medicinova Inc   0.06 
Day One Biopharmaceuticals Inc   0.06 
Pasithea Therapeutics Corp   0.06 
Rezolute Inc   0.06 
Lantern Pharma Inc   0.05 
Disc Medicine Inc   0.05 
Nuvalent Inc   0.05 
Theseus Pharmaceuticals Inc   0.05 
Belite Bio Inc  0.05 
Zomedica Corp   0.05 
Cyteir Therapeutics Inc   0.05 
Terns Pharmaceuticals Inc   0.05 
Xenon Pharmaceuticals Inc   0.05 
Design Therapeutics Inc   0.05 
Tyra Biosciences Inc   0.04 
Astria Therapeutics inc   0.04 
Altimmune Inc   0.04 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com